Inaccurate diagnosis in infants with pertussis. An eight-year experience

Insights

Diagnosing pertussis (whooping cough) in infants is often missed due to similar symptoms to other respiratory infections. Early suspicion and diagnosis are crucial for treatment and preventing spread.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Pertussis (whooping cough) remains a significant concern in pediatric populations.
  • Early and accurate diagnosis is critical for effective treatment and public health interventions.

Purpose of the Study:

  • To review cases of Bordetella pertussis infection identified via fluorescent antibody staining.
  • To compare clinical characteristics and diagnostic challenges of pertussis in hospitalized versus outpatient pediatric cases.
  • To identify key clinical indicators that aid in the timely diagnosis of pertussis.

Main Methods:

  • Retrospective review of nasopharyngeal specimens positive for Bordetella pertussis via fluorescent antibody staining.
  • Analysis of patient demographics, immunization status, admission diagnoses, and clinical courses.
  • Comparison of initial differential diagnoses recorded by house officers.

Main Results:

  • Pertussis was often misdiagnosed or not considered initially, with bronchiolitis being a common alternative diagnosis.
  • Severe coughing and frequent vomiting were identified as key clinical indicators for pertussis.
  • Younger age and lower immunization status correlated with more severe and prolonged illness.
  • Abnormal chest X-rays and elevated white blood cell counts were not consistently indicative of pertussis.

Conclusions:

  • The diagnosis of pertussis is frequently delayed or missed due to overlapping symptoms with other infant respiratory infections.
  • Increased clinical suspicion in infants presenting with nonspecific respiratory symptoms is essential for prompt diagnosis and management.
  • Early diagnosis facilitates appropriate treatment and prevents further transmission of Bordetella pertussis.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...